Organogenesis Holdings Inc. (NASDAQ:ORGO) Q1 2026 Earnings Call Transcript
Operator: Welcome, ladies and gentlemen, to the First Quarter 2026 Earnings Conference Call for Organogenesis Holdings, Inc.
Organogenesis Holdings Inc. (ORGO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bailard Inc Thomas Bailard | 36,812 | $87,244 | 0% | |
| 2. | Aster Capital Management (DIFC) Ltd Nabil Ouajjane | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.68 | 5,000 | $13,405.00 | 291,014 | 2026-03-09 | Filing | |
| $2.67 | 10,000 | $26,688.00 | 225,707 | 2026-03-09 | Filing | |
| $2.99 | 107,494 | $320,998.58 | 358,495 | 2025-05-15 | Filing | |
| $3.09 | 251,001 | $775,040.89 | 251,001 | 2025-05-14 | Filing | |
| $2.99 | 9,022 | $26,948.71 | 846,459 | 2025-06-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.14 | 200,000 | $1,027,060.00 | 2,565,591 | 2025-12-16 | Filing | |
| $5.29 | 187,957 | $994,292.53 | 2,765,591 | 2025-11-26 | Filing | |
| $5.30 | 12,043 | $63,827.90 | 2,953,548 | 2025-11-25 | Filing | |
| $5.34 | 100,000 | $534,000.00 | 2,965,591 | 2025-11-24 | Filing | |
| $3.56 | 18,620 | $66,255.55 | 335,719 | 2025-06-10 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,900,816 | $6,874,934 | 0% | |
| 2. | 2,891,006 | $6,850,893 | 0% | |
| 3. | 1,967,952 | $4,664,046 | 0.01% | |
| 4. | 1,705,681 | $4,042,464 | 0% | |
| 5. | 1,449,092 | $3,434,348 | 0% |
News See All
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2025 Earnings Call Transcript
Operator: Welcome, ladies and gentlemen, to the Fourth Quarter and Full Year 2025 Earnings Conference Call for Organogenesis Holdings, Inc.
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q3 2025 Earnings Call Transcript
Operator: Welcome, ladies and gentlemen, to the Third Quarter 2025 Earnings Conference Call of Organogenesis Holdings, Inc.
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q2 2025 Earnings Call Transcript
Operator: Welcome, ladies and gentlemen, to the Second Quarter 2025 Earnings Conference Call for Organogenesis Holdings, Inc.
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q1 2025 Earnings Call Transcript
Operator: Welcome, ladies and gentlemen, to the First Quarter 2025 Earnings Conference Call for Organogenesis Holdings Inc. At this time, all participants have been placed in a listen-only mode.
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2024 Earnings Call Transcript
Operator: Please standby. Welcome, ladies and gentlemen, to the Fourth Quarter and Fiscal Year 2024 Earnings Conference Call for Organogenesis Holdings, Inc.
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q3 2024 Earnings Call Transcript
Operator: Please stand by. Welcome ladies and gentlemen to the Third Quarter of Fiscal Year 2024 Earnings Conference Call for Organogenesis Holdings Inc.
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q2 2024 Earnings Call Transcript
Operator: Please stand by. Welcome ladies and gentlemen to the Second Quarter 2024 Earnings Conference Call for Organogenesis Holdings Inc.
10 Best NASDAQ Penny Stocks To Invest In
Penny stocks are companies that are trading under $5 per share. They represent a unique and controversial segment of the financial market.
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q1 2024 Earnings Call Transcript
Organogenesis Holdings Inc. beats earnings expectations. Reported EPS is $-0.02, expectations were $-0.03.
Hedge Fund Resource Center